Heinz, Amadeus T 
; Calkoen, Friso G.J. ; Derbich, Alexander ; Miltner, Lea ; Seitz, Christian ; Doering, Michaela ; Braun, Christiane ; Atar, Daniel ; Schumm, Michael ; Heubach, Florian ; Arendt, Anne-Marie ; Schulz, Ansgar ; Schuster, Friedhelm R ; Meisel, Roland ; Strahm, Brigitte ; Finke, Juergen ; Heineking, Beatrice ; Stetter, Susanne ; Silling, Gerda ; Stachel, Daniel ; Gruhn, Bernd ; Debatin, Klaus-Michael ; Foell, Juergen ; Schulte, Johannes H ; Woessmann, Wilhelm ; Mauz-Körholz, Christine ; Tischer, Johanna ; Feuchtinger, Tobias ; Handgretinger, Rupert ; Lang, Peter
; Calkoen, Friso G.J. ; Derbich, Alexander ; Miltner, Lea ; Seitz, Christian ; Doering, Michaela ; Braun, Christiane ; Atar, Daniel ; Schumm, Michael ; Heubach, Florian ; Arendt, Anne-Marie ; Schulz, Ansgar ; Schuster, Friedhelm R ; Meisel, Roland ; Strahm, Brigitte ; Finke, Juergen ; Heineking, Beatrice ; Stetter, Susanne ; Silling, Gerda ; Stachel, Daniel ; Gruhn, Bernd ; Debatin, Klaus-Michael ; Foell, Juergen ; Schulte, Johannes H ; Woessmann, Wilhelm ; Mauz-Körholz, Christine ; Tischer, Johanna ; Feuchtinger, Tobias ; Handgretinger, Rupert ; Lang, Peter 
Zusammenfassung
Therapy-resistant viral reactivations contribute significantly to mortality after hematopoietic stem cell transplantation. Adoptive cellular therapy with virus-specific T cells (VST) has shown efficacy in various single-center trials. However, the scalability of this therapy is hampered by laborious production methods. In this study we describe the in-house production of VST in a closed system ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Altmetric